Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parkinson Disease
|
990 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.900 | 0.996 | 260 | 2005 | 2020 | ||||
Familial (FPAH)
|
276 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 1.000 | 32 | 2006 | 2019 | ||||
Sporadic Parkinson disease
|
65 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 0.968 | 31 | 2005 | 2019 | ||||
Parkinsonian Disorders
|
95 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 0.958 | 24 | 2005 | 2020 | ||||
PARKINSON DISEASE, LATE-ONSET
|
76 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 1.000 | 19 | 2005 | 2019 | ||||
Movement Disorders
|
247 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.720 | 1.000 | 10 | 2004 | 2018 | ||||
Parkinson Disease, Familial, Type 1
|
27 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.100 | 1.000 | 10 | 2005 | 2015 | ||||
PARKINSON DISEASE 8 (disorder)
|
33 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.810 | 1.000 | 7 | 2005 | 2015 | ||||
Impaired cognition
|
348 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.070 | 0.857 | 7 | 2010 | 2020 | ||||
Dyskinetic syndrome
|
42 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.050 | 1.000 | 5 | 2007 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.050 | 0.800 | 5 | 2010 | 2020 | ||||
Primary malignant neoplasm
|
1374 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.050 | 0.800 | 5 | 2010 | 2020 | ||||
Alzheimer's Disease
|
1843 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 0.750 | 4 | 2007 | 2019 | ||||
Mitochondrial abnormalities
|
20 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 1.000 | 4 | 2011 | 2017 | ||||
Motor symptoms
|
15 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||
Sense of smell impaired
|
12 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.040 | 1.000 | 4 | 2008 | 2018 | ||||
Alzheimer Disease, Late Onset
|
243 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 0.667 | 3 | 2007 | 2009 | ||||
Depressed mood
|
269 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Depressive disorder
|
297 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Lewy Body Disease
|
41 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 0.667 | 3 | 2006 | 2016 | ||||
Mental Depression
|
271 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||
Autosomal Dominant Parkinsonism
|
3 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2005 | 2007 | ||||
Bradykinesia
|
16 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||
Central neuroblastoma
|
231 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Childhood Neuroblastoma
|
231 | 0.583 | 0.480 | 12 | 40340400 | missense variant | G/A | snv | 5.3E-04 | 3.6E-04 | 0.020 | 1.000 | 2 | 2012 | 2018 |